Evolent Health Balance Sheet Health
Financial Health criteria checks 4/6
Evolent Health has a total shareholder equity of $1.2B and total debt of $597.0M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are $2.7B and $1.4B respectively. Evolent Health's EBIT is $30.8M making its interest coverage ratio 0.6. It has cash and short-term investments of $192.8M.
Key information
47.9%
Debt to equity ratio
US$597.05m
Debt
Interest coverage ratio | 0.6x |
Cash | US$192.83m |
Equity | US$1.25b |
Total liabilities | US$1.43b |
Total assets | US$2.68b |
Recent financial health updates
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Is Evolent Health (NYSE:EVH) A Risky Investment?
Aug 05Recent updates
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Evolent Health: Improving Financials, But There's More
Aug 31Is Evolent Health (NYSE:EVH) A Risky Investment?
Aug 05Evolent Health initiated at outperform at RBC on organic revenue growth opportunity
Jul 29Evolent Health: Strong Growth, Priced At 2x Sales, What To Know
Jul 11Evolent Health: Healthy Growth, But That Is About It
Jun 30Financial Position Analysis
Short Term Liabilities: EVH's short term assets ($683.7M) exceed its short term liabilities ($674.2M).
Long Term Liabilities: EVH's short term assets ($683.7M) do not cover its long term liabilities ($759.9M).
Debt to Equity History and Analysis
Debt Level: EVH's net debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: EVH's debt to equity ratio has increased from 18.6% to 47.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable EVH has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: EVH is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 33.1% per year.